|
⚲
|
| Keyboard |
| Cummings James F
✚
|
|
|---|---|
| CIK # | 0001886760 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001886760] | |
| 4 | [0001886760] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Cummings James F | |
| NABI Biopharmaceuticals |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-28 | Tax withheld | 3,292 | $0.65 | 2,140 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-24 | Tax withheld | 30,551 | $0.69 | 21,080 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-18 | Tax withheld | 6,772 | $0.63 | 4,266 |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2026-03-16 | Grant | 455,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-16 | Grant | 227,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-02-02 | Tax withheld | 7,965 | $0.61 | 4,859 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-03-28 | Tax withheld | 3,292 | $0.42 | 1,383 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-03-24 | Grant | 406,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2025-03-24 | Grant | 50,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2025-03-24 | Grant | 610,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-03-18 | Tax withheld | 6,772 | $0.57 | 3,860 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-02-02 | Tax withheld | 7,964 | $0.68 | 5,416 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2024-03-28 | Tax withheld | 3,292 | $1.30 | 4,280 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2024-03-18 | Grant | 90,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2024-03-18 | Grant | 410,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2024-02-02 | Tax withheld | 7,965 | $1.20 | 9,558 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2023-12-08 | Tax withheld | 31,409 | $0.71 | 22,300 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2023-03-28 | Tax withheld | 3,267 | $0.75 | 2,450 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2023-03-17 | Grant | 90,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2023-03-17 | Grant | 205,000 | $0.00 | |
| showing 20 of 25 most recent transactions | |||||